| ACE | angiotensin-converting enzyme |
| ADNP | activity-dependent neurotrophic protein |
| AngI | angiotensin I |
| APJ | apelin receptor |
| AT1R and AT2R | angiotensin type I and type 2 receptors |
| B1R and B2R | bradykinin receptors 1 and 2 |
| BCCAO | bilateral common carotid artery occlusion |
| BRB | blood–retinal barrier |
| CGRP | calcitonin gene-related peptide receptor |
| CRF | corticotropin-releasing factor |
| DPP4 | dipeptidyl peptidase 4 |
| ERG | electroretinogram |
| GFAP | glial fibrillary acidic protein |
| GH | growth hormone |
| GHR | GH receptor |
| GHRH | GH-releasing hormone |
| GHSR-1a | GH secretagogue receptor type 1a |
| GLP-1 | glucagon-like peptide-1 |
| GLP-1R | GLP-1 receptor |
| HIF1-α | hypoxia-inducible factor 1α |
| IGF-1 | insulin-like growth factor-1 |
| iNOS | inducible NO synthase |
| IOP | intraocular pressure |
| MDMA | methylenedioxymethamphetamine |
| MC1-5R | melanocortin receptors 1-5 |
| MR | mineralocorticoid receptor |
| NAP | 8-amino acid peptide derived from ADNP |
| NK1-3R | NK receptors 1-3 |
| NKA and NKB | neurokinin A and B |
| NO | nitric oxide |
| NPY | neuropeptide Y |
| PAC1R | PACAP receptor 1 |
| PACAP | pituitary adenylate cyclase-activating polypeptide |
| PDR | proliferative diabetic retinopathy |
| RAS | renin–angiotensin system |
| ROS | reactive oxygen species |
| RPE | retinal pigment epithelium |
| SP | substance P |
| SRIF | somatotropin release inhibiting factor—somatostatin |
| sst1–5 | SRIF receptors 1-5 |
| STZ | streptozotocin |
| TNFα | tumor necrosis factor α |
| Ucn 2 | urocortin 2 |
| VEGF | vascular endothelial growth factor |
| VEGFRs | VEGF receptors |
| VIP | vasoactive intestinal peptide |
| VPAC1R and VPAC2R | VIP and PACAP receptors 1 and 2 |
| α-MSH | α-melanocyte-stimulating hormone |